Methods of reducing mammographic breast density and/or breast cancer risk
A technique for mammography, breast density, applied in the fields of reducing breast pain, androgen agents and aromatase inhibitors, reducing elasticity and/or reducing breast cell genome mechanics signaling, aromatase inhibitors
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0414] Example 1: Dose Administration Algorithm
[0415] Using the following dosage administration algorithm, subcutaneous granules containing a combination of testosterone and anastrozole were used to treat menopausal symptoms in 50-year-old women with high mammographic breast density, including painful breast cysts. After 1 year of treatment, the improvement of MBD was observed through mammography ( figure 1 Is a mammogram of the patient’s breast taken immediately before treatment, and figure 2 It is a mammogram of the patient's breast at 1 year (ie after 1 year of treatment).
[0416] FAI is calculated according to the formula, in which serum measurements of total testosterone and sex hormone binding protein are calculated by radioimmunoassay. The serum levels of aromatase inhibitors were determined by liquid chromatography-tandem mass spectrometry.
[0417] Dose schedule
[0418] Initial dose administration
[0419] Initial dose administration (androgen agent): TD=BW X TBF X MBD...
Embodiment 2
[0447] Example 2: Serum Anastrozole
[0448] Thirty women with high MDB have been treated in the past 18 months, and 20 of them must receive 2 mammograms for evaluation at baseline and 1 year (Table 1). Table 1 provides median values. All 30 women were drawn serum for serum testosterone and sex hormone binding protein at baseline and 1 year, so that the free androgen index (FAI=total testosterone level divided by sex hormone binding protein level can be calculated, and then multiplied by 100 to provide the percentage ). Serum anastrozole was calculated by liquid chromatography-tandem mass spectrometry.
[0449]
[0450]
[0451] Table 1
[0452] This example shows that the combination of testosterone and anastrozole administered subcutaneously at an interval of 4 months resulted in an increase in serum anastrozole within the treatment range and an increase in testosterone in the high physiological range (normal range is usually 0.2-7%). Valley level (as measured by FAI). Among t...
Embodiment 3
[0453] Example 3: Evaluation of breast stiffness reduction using mammography
[0454] Techniques have been developed that allow estimation of breast tissue stiffness based on variables from mammography. For example, this method is proposed in Boyd and the present disclosure. image 3 Show how to estimate the hardness of breast tissue based on the volume and area measurements described above by making three assumptions. First of all, this technology considers that the breast volume and projected area measured on the extruded breast are basically accurate measurements of these entities. It is also assumed that the shape of the uncompressed breast can be represented by a hemisphere and the shape of the mammography area can be represented by a semicircle. Regardless of the assumed shape, the measured breast volume remains essentially unchanged. The assumption that the shape of the uncompressed breast is a hemisphere enables the radius of the hemisphere to be calculated for comparis...
PUM
Property | Measurement | Unit |
---|---|---|
size | aaaaa | aaaaa |
hardness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com